Powers, John T.
Tsanov, Kaloyan M.
Pearson, Daniel S.
Roels, Frederik
Spina, Catherine S.
Ebright, Richard
Seligson, Marc
de Soysa, Yvanka
Cahan, Patrick
Theißen, Jessica
Tu, Ho-Chou
Han, Areum
Kurek, Kyle C.
LaPier, Grace S.
Osborne, Jihan K.
Ross, Samantha J.
Cesana, Marcella
Collins, James J.
Berthold, Frank
Daley, George Q.
Article History
Received: 2 February 2015
Accepted: 8 June 2016
First Online: 6 July 2016
Competing interests
: G.Q.D. holds options and intellectual property relating to 28/7 Therapeutics, a company seeking to develop inhibitors of the <i>LIN28</i>/<i>let-7</i> pathway.